Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Lilly Leaves Peers in Dust with Strong Growth Ranking

Guavy AI Editorial Team
Instruments
AMGN
Share

Eli Lilly is pulling ahead of its peers in the healthcare sector according to Seeking Alpha's recent rankings.

The company received a Buy-level growth grade, scoring an A and far outperforming other top holdings such as Intuitive Surgical, Johnson & Johnson, Gilead Sciences, and Amgen.

Lilly is already benefiting from high demand for its weight-loss and diabetes medications, giving it a distinct growth profile compared to the rest of the sector.

More on Stocks

Stocks just now

JPMorgan Bolsters Tech Investment Banking with Citi Hires

Stocks just now

JPMorgan Introduces Stock-Tracking Notes with Complex Pricing Structure

Stocks 1m ago

JPMorgan Sticks to $240 Price Target for SpaceX Amid AI Breakthroughs

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy